Asuri Prasad

Prof. Asuri Prasad

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2005 in Brain
Verified
Journal Article
Open access
PDF file
CFChristopher B. R. Funk
Christopher B. R. Funk
APAsuri Prasad
Asuri Prasad
PFPatrick Frosk
Patrick Frosk
SSSven Sauer
Sven Sauer
SKStefan Kölker
Stefan Kölker
MBMarc R. Del Bigio
Marc R. Del Bigio
Glutaric acidemia type 1 (GA-1) is an autosomal recessive disorder characterized by a deficiency of glutaryl-CoA dehydrogenase (GCDH) activity. GA-1 is often associated with an acute encephalopathy between 6 and 18 months of age that causes striatal damage resulting in a severe dystonic movement disorder. Ten autopsy cases have been previously described. Our goal is to understand the disorder better so that treatments can be designed. Therefore, we present the neuropathological features of six additional cases (8 months–40 years), all North American aboriginals with the identical homozygous mutation. This cohort displays similar pathological characteristics to those previously described. Four had macroencephaly. All had striatal atrophy with severe loss of medium-sized neurons. We present several novel findings. This natural time course study allows us to conclude that neuron loss occurs shortly after the encephalopathical crisis and does not progress. In addition, we demonstrate mild loss of large striatal neurons, spongiform changes restricted to brainstem white matter and a mild lymphocytic infiltrate in the early stages. Reverse transcriptase-PCR to detect the GCDH mRNA revealed normal and truncated transcripts similar to those in fibroblasts. All brain regions demonstrated markedly elevated concentrations of GA (3770–21 200 nmol/g protein) and 3-OH-GA (280–740 nmol/g protein), with no evidence of striatal specificity or age dependency. The role of organic acids as toxic agents and as osmolytes is discussed. The pathogenesis of selective neuronal loss cannot be explained on the basis of regional genetic and/or metabolic differences. A suitable animal model for GA-1 is needed.

14 September 2007 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
ASAjay P. Sharma
Ajay P. Sharma
CGCheryl R. Greenberg
Cheryl R. Greenberg
APAsuri Prasad
Asuri Prasad
CPChitra Prasad
Chitra Prasad

Verified
Journal Article
Open access
PDF file
SSSuvasini Sharma
Suvasini Sharma
APAsuri Prasad
Asuri Prasad
Inborn errors of metabolism (IEM) are a rare cause of epilepsy, but seizures and epilepsy are frequently encountered in patients with IEM. Since these disorders are related to inherited enzyme deficiencies with resulting effects on metabolic/biochemical pathways, the term “metabolic epilepsy” can be used to include these conditions. These epilepsies can present across the life span, and share features of refractoriness to anti-epileptic drugs, and are often associated with co-morbid developmental delay/regression, intellectual, and behavioral impairments. Some of these disorders are amenable to specific treatment interventions; hence timely and appropriate diagnosis is critical to improve outcomes. In this review, we discuss those disorders in which epilepsy is a dominant feature and present an approach to the clinical recognition, diagnosis, and management of these disorders, with a greater focus on primarily treatable conditions. Finally, we propose a tiered approach that will permit a clinician to systematically investigate, identify, and treat these rare disorders.

1 February 1996 in Epilepsia
Verified
Journal Article
Closed access
APAsuri Prasad
Asuri Prasad
CSCarl F. Stafstrom
Carl F. Stafstrom
GHGregory L. Holmes
Gregory L. Holmes

1 February 2000 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
CPChitra Prasad
Chitra Prasad
APAsuri Prasad
Asuri Prasad
BCBernard N Chodirker
Bernard N Chodirker
CLChristine Lee
Christine Lee
ADAngelika K Dawson
Angelika K Dawson
ACAlbert E Chudley
Albert E Chudley

1 August 1997 in Journal of Child Neurology
Verified
Journal Article
Open access
PDF file
APAsuri Prasad
Asuri Prasad
JBJoan C. Breen
Joan C. Breen
MAMary G. Ampola
Mary G. Ampola
NRN. Paul Rosman
N. Paul Rosman
Argininemia, a rare autosomal recessive urea cycle disorder, is caused by a deficiency of arginase, with resulting elevated plasma arginine and ammonia levels. Reports to date have focused little on the neurology of this disorder or the efficacy of treatments. A MEDLINE search revealed 25 previously reported cases, to which we have added two brothers who presented with late onset progressive spastic diplegia. Though their degree of enzyme deficiency was comparable, the severity of their phenotypic abnormalities differed substantially. With dietary therapy, both showed improved cognitive and motor function. Late metabolic crises occurred in both, resulting in death of the less severely affected brother. Based on analysis of our clinical database, we report on the full spectrum of neurologic abnormalities seen in argininemia with particular focus on the accompanying progressive spastic diplegia and its response to treatment; progressive decline in head growth; distinctive neuroradiologic findings; and life-threatening later complications. Current and potential future therapies and long-term outcome are summarized. (J Child Neurol 1997;12:301-309).